Could Delaware Become the Go-To State for Product Liability Lawsuits? Insights from the Zantac Case
Wilmington, Delaware — A recent wave of litigation centered around the heartburn medication Zantac is spotlighting Delaware as a potentially preferred venue for plaintiffs in pharmaceutical cases. The shift follows legal allegations that the drug, which was pulled from the market in 2020, may have caused cancer in numerous users. Legal experts suggest this trend toward filing in Delaware could be influenced by several key factors that make the state an attractive option for lawsuits. Delaware is renowned for its sophisticated understanding of corporate law, largely due to its role as a corporate domicile for … Read more